Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine.

Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S.

World J Hepatol. 2015 Oct 28;7(24):2503-9. doi: 10.4254/wjh.v7.i24.2503. Review.

2.

Population-Based Multicentric Survey of Hepatitis B Infection and Risk Factors in the North, South, and Southeast Regions of Brazil, 10-20 Years After the Beginning of Vaccination.

Ximenes RA, Figueiredo GM, Cardoso MR, Stein AT, Moreira RC, Coral G, Crespo D, Dos Santos AA, Montarroyos UR, Braga MC, Pereira LM; Hepatitis Study Group.

Am J Trop Med Hyg. 2015 Dec;93(6):1341-8. doi: 10.4269/ajtmh.15-0216. Epub 2015 Oct 26.

3.

Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPα Expression.

Chen YF, Chong CL, Wu YC, Wang YL, Tsai KN, Kuo TM, Hong MH, Hu CP, Chen ML, Chou YC, Chang C.

PLoS One. 2015 Jun 29;10(6):e0131743. doi: 10.1371/journal.pone.0131743. eCollection 2015.

4.

HBV Infection Among HIV-Infected Cohort and HIV-Negative Hospital Attendees in South Western Nigeria.

Adewumi MO, Donbraye E, Sule WF, Olarinde O.

Afr J Infect Dis. 2015;9(1):14-7.

5.

Multilevel factors influencing hepatitis B screening and vaccination among Vietnamese Americans in Atlanta, Georgia.

Frew PM, Alhanti B, Vo-Green L, Zhang S, Liu C, Nguyen T, Schamel J, Saint-Victor DS, Nguyen ML.

Yale J Biol Med. 2014 Dec 12;87(4):455-71. eCollection 2014 Dec.

6.

Risk factors for retrovirus and hepatitis virus infections in accepted blood donors.

Custer B, Kessler D, Vahidnia F, Leparc G, Krysztof DE, Shaz B, Kamel H, Glynn S, Dodd RY, Stramer SL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2015 May;55(5):1098-107. doi: 10.1111/trf.12951. Epub 2014 Dec 4.

7.

Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.

Ghaziani T, Sendi H, Shahraz S, Zamor P, Bonkovsky HL.

World J Gastroenterol. 2014 Oct 21;20(39):14142-55. doi: 10.3748/wjg.v20.i39.14142. Review.

8.

Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.

Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS; Hepatitis B Research Network; Hepatitis B Research Network.

Clin Gastroenterol Hepatol. 2015 Jan;13(1):183-92. doi: 10.1016/j.cgh.2014.06.028. Epub 2014 Jul 8.

9.

Tickling the TLR7 to cure viral hepatitis.

Funk E, Kottilil S, Gilliam B, Talwani R.

J Transl Med. 2014 May 14;12:129. doi: 10.1186/1479-5876-12-129. Review.

10.

Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection.

Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KB, Herlim M, Yang YX, Hennessy S, Kostman JR, Leonard MB, Localio AR, Lo Re V 3rd.

J Hepatol. 2014 Aug;61(2):210-8. doi: 10.1016/j.jhep.2014.04.001. Epub 2014 Apr 5.

11.

Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007.

Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KB, Herlim M, Yang YX, Hennessy S, Kostman JR, Leonard MB, Localio R, Lo Re V 3rd.

Ann Epidemiol. 2014 Jun;24(6):418-23. doi: 10.1016/j.annepidem.2014.02.013. Epub 2014 Mar 5.

12.

Prevalence and factors associated with hepatitis B virus infection among senior citizens in a southern brazilian city.

de Paula Machado DF, Martins T, Trevisol DJ, Vieira E Silva RA, Narciso-Schiavon JL, Schuelter Trevisol F, Schiavon Lde L.

Hepat Mon. 2013 Apr 30;13(5):e7874. doi: 10.5812/hepatmon.7874. Print 2013 May.

13.

PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Seem DL, Lee I, Umscheid CA, Kuehnert MJ; United States Public Health Service.

Public Health Rep. 2013 Jul;128(4):247-343. No abstract available.

14.

Hepatitis B and C in African Americans: current status and continued challenges.

Forde KA, Tanapanpanit O, Reddy KR.

Clin Gastroenterol Hepatol. 2014 May;12(5):738-48. doi: 10.1016/j.cgh.2013.06.006. Epub 2013 Jun 28. Review.

15.

Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California Valley.

Sheikh MY, Atla PR, Ameer A, Sadiq H, Sadler PC.

Gut Liver. 2013 Jan;7(1):66-73. doi: 10.5009/gnl.2013.7.1.66. Epub 2012 Dec 14.

16.

Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional study.

Zhang Y, Fang W, Fan L, Gao X, Guo Y, Huang W, Du Y.

Virol J. 2013 Jan 18;10:25. doi: 10.1186/1743-422X-10-25.

17.

Low rates of hepatitis B virus screening at the onset of chemotherapy.

Hwang JP, Fisch MJ, Zhang H, Kallen MA, Routbort MJ, Lal LS, Vierling JM, Suarez-Almazor ME.

J Oncol Pract. 2012 Jul;8(4):e32-9. doi: 10.1200/JOP.2011.000450. Epub 2012 Jun 12.

19.

Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran.

Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, Kabiri A, Ghanooni AH, Iranikhah A, Alavian SM.

Hepat Mon. 2012 Feb;12(2):112-7. doi: 10.5812/hepatmon.822. Epub 2012 Feb 29.

20.

Estimating the prevalence of chronic hepatitis B virus infection--New York City, 2008.

France AM, Bornschlegel K, Lazaroff J, Kennedy J, Balter S.

J Urban Health. 2012 Apr;89(2):373-83. doi: 10.1007/s11524-011-9653-7.

Items per page

Supplemental Content

Write to the Help Desk